Brief: Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
Oct 22 (Reuters) - Charles River Laboratories International Inc CRL.N: CHARLES RIVER AND THE FRANCIS CRICK INSTITUTE COMBINE EXPERTISE IN ANTIBODY-DRUG CONJUGATE DEVELOPMENT Source text: ID:nBwbyVzwZa Further company coverage: CRL.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charles River Laboratories International
See all newsS&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
European life sciences stocks rise on strong sector momentum
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT